Abstract
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have